Evidence map›Paper›PMID 29305504›Full record

ArticleApplied and environmental microbiology2018

An IgaA/UmoB Family Protein from Serratia marcescens Regulates Motility, Capsular Polysaccharide Biosynthesis, and Secondary Metabolite Production.

Nicholas A Stella, Kimberly M Brothers, Jake D Callaghan, Angelina M Passerini, Cihad Sigindere, Preston J Hill, Xinyu Liu, Daniel J Wozniak, Robert M Q Shanks

Open access · bronzeAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Thermoregulation of Prodigiosin Biosynthesis byPolish journal of microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Nicholas A StellaCharles T. Campbell Laboratory of Ophthalmic Microbiology, Department of Ophthalmology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Kimberly M BrothersCharles T. Campbell Laboratory of Ophthalmic Microbiology, Department of Ophthalmology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Jake D CallaghanCharles T. Campbell Laboratory of Ophthalmic Microbiology, Department of Ophthalmology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Angelina M PasseriniCharles T. Campbell Laboratory of Ophthalmic Microbiology, Department of Ophthalmology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Cihad SigindereDepartment of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Preston J HillCenter for Microbial Interface Biology, Departments of Microbial Infection and Immunity, Microbiology, Ohio State University, Columbus, Ohio, USA.
Xinyu LiuDepartment of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Daniel J WozniakCenter for Microbial Interface Biology, Departments of Microbial Infection and Immunity, Microbiology, Ohio State University, Columbus, Ohio, USA.
Robert M Q ShanksCharles T. Campbell Laboratory of Ophthalmic Microbiology, Department of Ophthalmology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA shanksrm@upmc.edu.ORCID https://orcid.org/0000-0002-7699-5396
University of Pittsburgh · USInterface (United States) · US

Funding

Virus Production and Manipulation of Protein/Gene Expression ModuleP30EY008098 · NEI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Marlene Behrmann · 1989 to 2026
$17.8M
Interdisciplinary Visual Sciences (IVS) Traininig ProgramT32EY017271 · NEI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Marlene Behrmann, Paul R. Kinchington · 2008 to 2026
$3.6M
NOT-NS-20-030: Use of anchored biologics to treat vesicant induced neovascularizationR01EY027331 · NEI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SHANKS, ROBERT M · 2017 to 2021
$1.8M
Impediment of corneal cell migration by a bacterial factorF32EY024785 · NEI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BROTHERS, KIMBERLY M · 2015 to 2016
$112k
NEI NIH HHS F32 EY024785NEI NIH HHS P30 EY008098NEI NIH HHS R01 EY027331NEI NIH HHS T32 EY017271
6 · The paper itself

Abstract

Secondary metabolites are an important source of pharmaceuticals and key modulators of microbe-microbe interactions. The bacterium

Indexed as

Bacterial ProteinsDepsipeptidesMembrane ProteinsMutationProdigiosinSequence Analysis, DNASerratia marcescensBacterial ProteinsDepsipeptidesMembrane ProteinsProdigiosinserratamolidebiofilmcapsular polysaccharidecompetitionflagellamotilitysecondary metabolitesurfactant

Identifiers

PMID29305504
PMCPMC5835751
OpenAlexW2783882258

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.